BIOSTIME INTL
BIOSTIME INTL operates in Diversified Metals & Mining.
BIOSTIME INTL (8BI) - Total Assets
Latest total assets as of December 2023: €20.04 Billion EUR
Based on the latest financial reports, BIOSTIME INTL (8BI) holds total assets worth €20.04 Billion EUR as of December 2023.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
BIOSTIME INTL - Total Assets Trend (2016–2023)
This chart illustrates how BIOSTIME INTL’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
BIOSTIME INTL - Asset Composition Analysis
Current Asset Composition (December 2023)
BIOSTIME INTL's total assets of €20.04 Billion consist of 25.6% current assets and 74.4% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 6.8% |
| Accounts Receivable | €1.04 Billion | 5.2% |
| Inventory | €2.37 Billion | 11.9% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €5.58 Billion | 27.9% |
| Goodwill | €7.82 Billion | 39.0% |
Asset Composition Trend (2016–2023)
This chart illustrates how BIOSTIME INTL's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: BIOSTIME INTL's current assets represent 25.6% of total assets in 2023, a decrease from 31.2% in 2016.
- Cash Position: Cash and equivalents constituted 6.8% of total assets in 2023, down from 10.6% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 66.0% of total assets, an increase from 58.0% in 2016.
- Asset Diversification: The largest asset category is goodwill at 39.0% of total assets.
BIOSTIME INTL Competitors by Total Assets
Key competitors of BIOSTIME INTL based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MANHATTAN ASSOC
BE:MHT
|
Germany | €698.14 Million |
|
TV BROADCAST
MU:TBCN
|
Germany | €6.25 Billion |
|
FIRST CITIZENS BC A
BE:FC6A
|
Germany | €220.57 Billion |
|
COSTCO WHSL
MU:CTO
|
Germany | €69.83 Billion |
|
GOLDMAN SACHS GROUP - Dusseldorf Stock Exchang
DU:GOS
|
Germany | €1.73 Trillion |
|
BURCKHARDT COMPRE N
MU:B5H
|
Germany | €1.07 Billion |
|
Public Service Company of New Mexico PFD 4.58%
PINK:PNMXO
|
USA | $886.19 Million |
|
2H0
F:2H0
|
Germany | €15.27 Million |
BIOSTIME INTL - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - BIOSTIME INTL generates 0.69x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, BIOSTIME INTL generates $ 2.90 in net profit.
BIOSTIME INTL - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.61 | 1.14 | 1.49 |
| Quick Ratio | 0.33 | 0.64 | 0.95 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-3.31 Billion | € 724.54 Million | € 1.64 Billion |
BIOSTIME INTL - Advanced Valuation Insights
This section examines the relationship between BIOSTIME INTL's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -4.4% |
| Total Assets | €20.04 Billion |
| Market Capitalization | $14.15K USD |
Valuation Analysis
Below Book Valuation: The market values BIOSTIME INTL's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: BIOSTIME INTL's assets decreased by 4.4% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for BIOSTIME INTL (2016–2023)
The table below shows the annual total assets of BIOSTIME INTL from 2016 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | €20.04 Billion | -4.39% |
| 2022-12-31 | €20.96 Billion | +3.36% |
| 2021-12-31 | €20.28 Billion | +17.79% |
| 2020-12-31 | €17.22 Billion | +8.56% |
| 2019-12-31 | €15.86 Billion | +6.78% |
| 2018-12-31 | €14.85 Billion | +5.12% |
| 2017-12-31 | €14.13 Billion | -0.52% |
| 2016-12-31 | €14.21 Billion | -- |